These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 11431175
1. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy. Wong TY, Szeto CC, Chow KM, Chan JC, Li PK. Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175 [Abstract] [Full Text] [Related]
2. Prognostic role of serum ACE activity on outcome of type 2 diabetic patients on chronic ambulatory peritoneal dialysis. Wong TY, Szeto CC, Chow KM, Chan JC, Li PK. Am J Kidney Dis; 2002 May; 39(5):1054-60. PubMed ID: 11979350 [Abstract] [Full Text] [Related]
4. Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese. Thomas GN, Critchley JA, Tomlinson B, Lee ZS, Young RP, Cockran CS, Chan JC. Clin Nephrol; 2001 Jan; 55(1):7-15. PubMed ID: 11200871 [Abstract] [Full Text] [Related]
5. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients]. Moleda P, Majkowska L, Safranow K, Adler G, Goracy I. Przegl Lek; 2007 Jan; 64(3):134-9. PubMed ID: 17941464 [Abstract] [Full Text] [Related]
10. No association between the angiotensin-converting-enzyme gene insertion/deletion polymorphism and the occurrence of macroangiopathy in patients with diabetes mellitus type 2. Klemm T, Mittrach-Schorin S, Neumann S, Gerike T, Krankenberg H, Schuler G, Paschke R. Horm Metab Res; 2003 Jan 20; 35(1):43-7. PubMed ID: 12669270 [Abstract] [Full Text] [Related]
11. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G. Diabetologia; 1997 Mar 20; 40(3):327-31. PubMed ID: 9084972 [Abstract] [Full Text] [Related]
12. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy]. Levinson O, Oren S, Yagil C, Sapojnikov M, Wechsler A, Bloch R, Yagil Y. Harefuah; 1999 May 16; 136(10):768-73, 843. PubMed ID: 10955109 [Abstract] [Full Text] [Related]
15. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Bozkurt O, Verschuren WM, van Wieren-de Wijer BM, Knol MJ, de Boer A, Grobbee DE, Geerlings MI, Heerdink ER, Klungel OH. J Hum Hypertens; 2008 Nov 16; 22(11):774-80. PubMed ID: 18563171 [Abstract] [Full Text] [Related]
18. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, Berdeli A, Akin M. J Renin Angiotensin Aldosterone Syst; 2005 Mar 16; 6(1):38-42. PubMed ID: 16088850 [Abstract] [Full Text] [Related]
19. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population. Ravn LS, Benn M, Nordestgaard BG, Sethi AA, Agerholm-Larsen B, Jensen GB, Tybjaerg-Hansen A. Pharmacogenet Genomics; 2008 Jun 16; 18(6):525-33. PubMed ID: 18496132 [Abstract] [Full Text] [Related]
20. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS. Singapore Med J; 2008 Nov 16; 49(11):924-9. PubMed ID: 19037561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]